首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   866篇
  免费   113篇
  国内免费   1篇
耳鼻咽喉   12篇
儿科学   52篇
妇产科学   26篇
基础医学   50篇
口腔科学   3篇
临床医学   67篇
内科学   150篇
皮肤病学   5篇
神经病学   33篇
特种医学   48篇
外科学   415篇
综合类   22篇
预防医学   13篇
眼科学   10篇
药学   17篇
肿瘤学   57篇
  2024年   5篇
  2023年   20篇
  2022年   5篇
  2021年   12篇
  2020年   55篇
  2019年   12篇
  2018年   40篇
  2017年   28篇
  2016年   36篇
  2015年   20篇
  2014年   48篇
  2013年   63篇
  2012年   34篇
  2011年   41篇
  2010年   41篇
  2009年   65篇
  2008年   33篇
  2007年   28篇
  2006年   41篇
  2005年   32篇
  2004年   40篇
  2003年   11篇
  2002年   17篇
  2001年   16篇
  2000年   6篇
  1999年   11篇
  1998年   14篇
  1997年   11篇
  1996年   11篇
  1995年   10篇
  1993年   7篇
  1992年   9篇
  1991年   9篇
  1990年   6篇
  1989年   8篇
  1988年   10篇
  1987年   5篇
  1986年   8篇
  1985年   8篇
  1984年   11篇
  1983年   6篇
  1982年   5篇
  1979年   8篇
  1978年   8篇
  1977年   5篇
  1976年   7篇
  1975年   7篇
  1974年   5篇
  1973年   12篇
  1971年   4篇
排序方式: 共有980条查询结果,搜索用时 15 毫秒
1.
2.
3.
The effect of established infection with penicillin-resistant staphylococcus aureus on m'icrbarterial anastomosis was studied in an experimental model. The infection was treated with wound debridement and systemic antibiotics before the surgical procedure. It was found that the anastomotic patency rate of microarte-rial repair was 95.1%. The presence of established infection, if properly treated, should not be a contraindication to microarterial surgery.  相似文献   
4.
5.
Background: Angiogenesis is essential for tumor growth and metastasis. Vascular endothelial growth factor (VEGF) is the most potent angiogenic factor identified to date. TGFβ-1 acts as an indirect angiogenic agent. Methods: VEGF and TGFβ-1 were measured in the serum of breast cancer patients and agematched controls and in tumor tissue of cancer patients by ELISA. VEGF protein and mRNA expression by breast tumor cell lines were examined, and the effect of TGFβ-1 on VEGF production in these cells was assessed. Results: VEGF levels were significantly higher (P=.03) in the serum of patients with breast cancer compared to age-matched controls. A positive correlation was found between serum (r=0.539) and tumor tissue (r=0.688) levels of VEGF and TGFβ-1. Metastatic MDA-MB-231 breast cancer cells produce more VEGF than do the primary BT474 cells. TGFβ-1 significantly (P<.05) increased production of VEGF. Conclusions: Breast cancer cells constitutively produce VEGF protein and mRNA. There is a relationship between VEGF and TGFβ-1 levels in breast cancer patients, and TGFβ-1 regulates VEGF expression by breast cancer cells. Presented at the 50th Annual Cancer Symposium of the Society of Surgical Oncology, Chicago, Illinois, March 20–23, 1997.  相似文献   
6.
7.
8.
Background. Heparin bonding of the cardiopulmonary bypass (CPB) circuit may be associated with a reduced inflammatory response and improved clinical outcome. The relative contribution of a heparin-bonded oxygenator (ie, >80% of circuit surface area) to these effects was assessed in a group of pediatric patients.

Methods. Twenty-one pediatric patients undergoing CPB operations were assigned randomly to receive either a heparin-bonded oxygenator (group H, n = 11) or a nonbonded oxygenator (group C, n = 10) in otherwise nonbonded circuits. The two groups were similar in pathology, age, weight, CPB time, and cross-clamp time. Plasma levels of the cytokines tumor necrosis factor-, interleukin-6, and interleukin-8, as well as terminal complement complex, neutrophils, and elastase, were analyzed before, during, and after CPB.

Results. Significant levels of tumor necrosis factor- were not detected in either group. Plasma levels of all other markers increased during and after CPB compared with baseline. Plasma levels of interleukin-6 peaked in both groups 2 hours after the administration of protamine but remained significantly higher in group C 24 hours after operation. Plasma concentrations of interleukin-8 peaked at similar levels in both groups 30 minutes after protamine administration and returned to baseline thereafter. Levels of terminal complement complex and elastase peaked in both groups 30 minutes after protamine administration. Plasma levels of terminal complement complex were significantly higher at the end of CPB and after protamine administration in group C. Elastase levels were significantly higher 2 and 24 hours after CPB in group C. The ventilation time of patients in group H was significantly lower than that of patients in group C: 10 (range, 3 to 24) versus 22 (range, 7 to 24) hours, respectively (p < 0.01).

Conclusions. The present study confirms the proinflammatory nature of pediatric operations and demonstrates a lessened systemic inflammatory response with the use of heparin-bonded oxygenators. This is achieved without bonding of the entire circuit, which could have significant cost-benefit implications by negating the need for custom-built heparin-bonded circuitry.  相似文献   

9.
A primary cardiac osteogenic sarcoma is described in a patient presenting with a left atrial obstructive lesion. Wide surgical excision was possible with left atrial reconstruction and mitral valve replacement. The patient survived the operation and was symptom free for 1 year, finally dying at 18 months of cerebral metastases.  相似文献   
10.
The choice of a surgical approach for multi-level cervical spondylotic myelopathy (CSM) and ossification of the posterior longitudinal ligament (OPLL) is still a controversial issue. While most of the surgeons are still performing decompression by laminectomy some are doing multi-level anterior decompression. Few neurosurgeons are performing decompression by corpectomy. We have treated 26 patients by median cervical corpectomy during the last 4 years. These patients were followed up for a mean period of 25 months. Twenty one (80%) patients had a good outcome, 2 patients remained unchanged and 3 expired. Review of the literature and our experience indicates that patients with CSM and OPLL should be operated by median cervical corpectomy (anterior approach).  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号